Roche Diagnostics

FDA Regulatory Profile

Roche Diagnostics appears in FDA public data with 0 recalls, 453 510(k) clearances, 24 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on Aug 19, 2026.

Summary

Total Recalls
0
510(k) Clearances
453
Inspections
24
Compliance Actions
0

Known Names

Roche Diagnostics, Roche Diagnostics Corporation, Roche Diagnostics Operations

Recent 510(k) Clearances

K-NumberDeviceDate
K261686Elecsys Phospho-Tau (217P) PlasmaAug 19, 2026
K252323cobas pulse blood glucose monitoring systemJun 12, 2026
K252431Elecsys CalcitoninApr 24, 2026
K252280Elecsys Anti-SARS-CoV-2 SApr 13, 2026
K260048Elecsys Anti-HAV IgMApr 7, 2026
K260049Elecsys Anti-HBc IgMApr 7, 2026
K260046Elecsys Anti-HBc IIApr 7, 2026
K260026Tina-quant Cardiac high sensitivity CRP IIIApr 2, 2026
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integratedFeb 12, 2026
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsFeb 12, 2026
K253839Elecsys Anti-SARS-CoV-2Dec 17, 2025
K253188CoaguChek XS Plus SystemOct 24, 2025
K252163Elecsys Phospho-Tau (181P) PlasmaOct 8, 2025
K242505Elecsys Cortisol IIIJul 17, 2025
K250768Elecsys Anti-SARS-CoV-2Jun 10, 2025
K241453Elecsys sFlt-1 and Elecsys PlGFFeb 7, 2025
K233060Elecsys Folate IIIJun 17, 2024
K220272cobas pulse blood glucose monitoring systemApr 26, 2024
K231927Elecsys PTH , Elecsys PTH STATMar 22, 2024
K221890Elecsys Tg IISep 30, 2023